IARS, AUA and SOCCA 2021 ABSTRACT SUBMISSIONS
Abstract submission for the IARS, AUA and SOCCA 2021 Annual Meetings closed on January 17, 2021. Notifications on abstract status will be sent by March 2021.
IARS Late Breaking Abstract Submission is Now Open
The IARS late-breaking abstract category allows for the submission of truly late-breaking, high-impact scientific research for which results were not available at the time of the general abstract submission deadline. Late-breaking abstracts should present data that are high impact, ground breaking, innovative, and newsworthy. This category is not a mechanism to allow for updated data to be submitted later when preliminary data were available by the general abstract submission deadline. Medically challenging cases are not accepted for late-breaking submission.
All abstracts must be submitted online. Late-breaking abstract notifications will be sent via email in April 2021.
Deadline to Submit: March 5, 2021, 11:59pm EST
The online abstract submission form will request for the following information:
*Indicates a required field
References: List references in the order in which they appear in the abstract. Cite only the name of the publication, volume, page number, and year.
Describe the purpose of the study.
- *Stage of research:
Indicate your stage of research (select 1).
- Clinical Study
- Preclinical Study
- *Area of focus for research:
Select the area of focus for your research (select 1).
- Basic Science Research
- Clinical Research
Economics, Education and Policy
Neuroscience in Anesthesiology and Perioperative Medicine
Technology, Computing and Simulation, Equipment Monitoring
- *Presenting Author Level of Training (Select one)
- 1-6 Years after Training
- 7-10 Years after Training
- 11 or More Years after Training
There is a limit of five (5) images or charts per abstract. The images / charts are not included in the total character count. You may only upload files that are 200 MB or less and in one of the following file formats: jpg, gif, pdf, doc, or docx.
- The Late-Breaking Abstract submission site does not accept Medically Challenging Case submissions.
- Revisions are not allowed after the deadline. The abstract will be listed in all program materials as submitted.
- There are no restrictions on the number of submissions per submitter.
- The abstract text must be in English.
- The Introduction, Methods, Results and Conclusions sections cannot exceed 4500 characters (including spaces) total. Each section cannot exceed 2500 characters (including spaces).
- Brand Names are prohibited. Please use the generic name.
- Abstract reviews are blinded. Do not include the institution in the abstract body or title.
- Research presented at the IARS 2021 Annual Meeting should not be published in an indexed journal prior to the IARS 2021 Annual Meeting.
- Human subjects should not be identifiable. Do not disclose patients’ names, initials, hospital numbers, dates of birth, or other protected health care information.
- Please review the WMA Declaration of Helsinki – Ethical Principles for Medical Research Involving Human Subjects: https://www.wma.net/policies-post/wma-declaration-of-helsinki-ethical-principles-for-medical-research-involving-human-subjects/.
- Retain copies of the IRB approval and documentation of written informed consent from each study subject.
- Please review the US Department of Health & Human Services Guidelines: https://www.hhs.gov/hipaa/for-professionals/privacy/special-topics/de-identification/index.html#standard.
- Research performed in vertebrate animals must explicitly state that the study was approved by the authors’ IRB for animal research (e.g., the Institutional Animal Care and Use Committee).
- Please review the US Public Health Service Policy on Humane Care and Use of Laboratory Animals: https://olaw.nih.gov/policies-laws/phs-policy.htm.
SUBMISSION BEST PRACTICES
- Originality and Scientific Merit: Were novel concepts or approaches used? Does the abstract challenge existing paradigms or develop new methodologies or technologies? Does the abstract address an important problem? Was scientific knowledge advanced?
- Quality and Integrity of Research Design and Data Analysis: Is the study design clearly described? Are issues of reliability and validity of the measures addressed? Are the statistical analyses appropriate?
- Conclusions: Are conclusions clearly stated? How well are the conclusions justified by the data?
- Technical Writing: Is the abstract clearly written and well-organized, or is the abstract difficult to follow and unfocused? Are there virtually no spelling, punctuation, or grammatical errors, or do the errors pose a distraction to the content provided in the abstract submission?